Prof. Ehab Said Ibrahim Eldesoky
Assiut university, Egypt
Email: ehegypt@yahoo.com
Qualifications
1994 M.D., Assiut University, Pharmacology
1989 M.Sc., Assiut University, Pharmacology
1984 M.B., Tanta University, Medicine
Publications (Selected)
-
Ehab S. EL Desoky, Eman. M. Khedr,
Mohamed. S. Khalil and Thomas Gasser. Genetic Analysis of
Leucin-Rich Repeat Kinase 2 (LRRK2) G2019S Mutation in a Sample of Egyptian
Patients with Parkinson's Disease, a Pilot Study. British Journal of
Medicine & Medical Research 2015, 5 (3): 404-408.
-
Ehab S. EL Desoky. The AMPA
receptor antagonist perampanel is a new hope in the treatment for
epilepsy. Fundamental and Clinical Pharmacology. 2014; 28 (5): 473-80.
-
Ehab S. EL Desoky. Mohamed H Ghazal,
Rajendra P Singh, Omnia N Abdelhamid , Hartmut Derendorf . Population
Pharmacokinetics of Methotrexate in Egyptian Children with Lymphoblastic
Leukemia. Pharmacology and Pharmacy. 2013; 4: 139-145.
-
E. S. EL Desoky, S. N. Sabarinath, M.
M. Hamdi, M. Bewernitz and H. Derendorf. Population
pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy
patients. Journal of Clinical Pharmacy and Therapeutics, 2012, 37,
352–355.
-
Ehab S. ELDesoky. Drug therapy of heart failure. An immunological view. Am JTher. Accepted for publication in December 2009 (Review).
-
Ehab S. ELDesoky, Sherif I. Kamel, Ahlam M. Farghaly, Madiha Y. Bakheet, Mohsen A. Hedaya and Jean-Pascal Siest. Study of the urinary ratio of 6 β-hydroxycortisol/cortisol as abiomarker of CYP3A4 activity in Egyptian patients with chronic liver disease. Drug Target Insights 2006, 2: 157-164.
-
Ehab S. ELDesoky, Ihab A. Fouad. Pharmacological Evidence for the Role of Nitric Oxide-cGMP in antinociception.The Journal of Applied Research 2005; 5: 451-59.
-
Ehab EL Desoky Mahmoud R. Kandil, Abdel-Halim M. Afifi, and Ossama M. Mostafa. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.Pharmacol Res 1999;39: 269-274.
-
Ehab S.ELDesoky, Ahlam M. Ahmed, Mohamed A Nafeh, Hanan Abd EL-Aty Ahmed, Ekkehard Schutz, Victor W. Armstrong and Michael Oellerich. Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis. Clin Biochem 1999;32: 207-212.
-
Ehab S.ELDesoky, Asmaa H Shoreit. Once versus twice daily administration of amikacin in pediatric patients with bronchopneumonia: plasma drug concentration and Bayesian pharmacokinetic estimation. Ann Pharmacother. 1999;33:749-750.
-
Raymond G. Morris; Benedetta C. Sallustio; Alexander A. T. M. M. Vinks; Donald F. LeGatt; Zulfikarali H. Verjee; Ehab El Desoky. Some international approaches to aminoglycoside monitoring in the extended dosing interval era. Ther Drug Minit 1999; 21: 379-388.
-
Ehab ELDesoky , Mohammed MA Khalifa, Jehan A Mahmoud, Salwa AT Ebraheemand U Klotz.Disposition and clinical efficacy of methotrexate in patients with rheumatoid arthritis following weekly low intramuscular dosing: a pilot study. Curr Ther Res 1997; 58: 434-445.
-
Ehab El Desoky E, Mohamed H Ghazal, Moussa A Mohamed, Ulrich Klotz.Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs. Direct pharmacokinetic calculations.Jpn J Pharmacol 1997; 75: 13-20.
-
U. Gladziwa, S. Wagner, K. V. Dakshinamurty , E. ElDesoky , B. Dreuw , and U. Klotz .Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis.Eur J Clin Pharmacol 1993; 44: 357-360.
-
E. ELDesoky and U Klotz. Value, limitations, and clinical impact of therapeutic drug monitoring in adults. Drug Invest 1993; 6: 127-136.
Profile Details
Last Updated: July, 2015.
Reference this profile directly: NULL